ICON Public Limited Company
ICLR
Rang in aandelen
#1654
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Aandeelprijs
$168.25
Laatst gesynchroniseerd: 2026-10-16
Marktkapitalisatie
$12.98B
Verandering (1 dag)
-3.93%
Verandering (1 jaar)
-9.08%
Land
IE
Handel ICON Public Limited Company (ICLR)
Categorie
Healthcare
Operationele marge voor ICON Public Limited Company (ICLR)
Operationele marge op October 2026 TTM: 10.15%
Volgens de meest recente financiële rapporten en aandelenkoers van ICON Public Limited Company is de huidige operationele marge (TTM) 10.15%. Eind 2023 had het bedrijf een operationele marge van 11.78%.
Geschiedenis van de operationele marge van ICON Public Limited Company van 2001 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 10.15% | -23.45% |
| 2024 | 13.26% | 12.56% |
| 2023 | 11.78% | 14.70% |
| 2022 | 10.27% | 48.63% |
| 2021 | 6.91% | -50.64% |
| 2020 | 14.00% | -9.39% |
| 2019 | 15.45% | 7.44% |
| 2018 | 14.38% | -25.26% |
| 2017 | 19.24% | 2.89% |
| 2016 | 18.70% | 4.59% |
| 2015 | 17.88% | 32.84% |
| 2014 | 13.46% | 48.40% |
| 2013 | 9.07% | 39.54% |
| 2012 | 6.50% | 56.63% |
| 2011 | 4.15% | -59.43% |
| 2010 | 10.23% | -15.52% |
| 2009 | 12.11% | 5.30% |
| 2008 | 11.50% | 4.74% |
| 2007 | 10.98% | 4.57% |
| 2006 | 10.50% | 83.57% |
| 2005 | 5.72% | -50.60% |
| 2004 | 11.58% | 4.89% |
| 2003 | 11.04% | -5.07% |
| 2002 | 11.63% | 22.04% |
| 2001 | 9.53% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 17.97% | -98.23% |
US
|
|
| 20.42% | -97.99% |
US
|
|
| -10.70% | -101.05% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -97.81% |
US
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.